By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Source BioScience today announced a collaboration with Illumina and Barts Cancer Institute for the development of an integrated genetic test for characterizing cancer tumors at the molecular level.

The goal is to develop the test to improve cancer diagnosis and treatment outcomes for patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.